Life Scientist > Lab Technology

NZ's Blis targets Chinese market

04 November, 2003 by Graeme O'Neill

Dunedin biotech Blis Technologies has opened a portal into a potential AUD$200 million market by signing a deal with Auckland-based Asia-Pacific Biotech Distributors to take its antibacterial Throat Guard into China.


Ventracor raises $33m in rights issue

29 October, 2003 by Melissa Trudinger

Ventracor (ASX:VCR) has closed its renounceable rights issue, raising approximately AUD$33 million in an offer oversubscribed by $12 million.


Amrad aims to regain its footing

27 October, 2003 by Melissa Trudinger

If you'd asked him a year ago whether he could see himself as CEO of Amrad, Dr Peter Smith would have said not likely.


Gradipore faces shareholder-driven rebellion

24 October, 2003 by Melissa Trudinger

Just weeks after a new CEO was appointed, embattled bioseparations company Gradipore has lost almost its entire board of directors in a shareholder-driven rebellion against the management of the company.


AusBiotech appoints policy and comms officer

15 October, 2003 by Melissa Trudinger

Industry association AusBiotech is moving to cement its role as an advocate for Australia's biotechnology industry, with the appointment of former SDA Biotech principal Paris Brooke to a newly created role in policy and communications.


Tight budget at Monash forces Metabolic sell-off

15 October, 2003 by Graeme O'Neill

In a drastic move to raise more funds for medical research, Monash University has sold off 6 million of its shares in promising Victorian biotech Metabolic Pharmaceuticals (ASX:MBP).


Two new businesses for biotech hub

13 October, 2003 by Tanya Hollis

Sydney's Australian Technology Park biotech hub has grown to nine companies with two new businesses recently joining the BioFirst precinct.


Biotechs, VCs need to get real, says UK venture capitalist

09 October, 2003 by Melissa Trudinger

Both biotechnology companies and venture capitalists need to be more realistic about the opportunities and outcomes available to them, a British venture capitalist told a Melbourne forum yesterday.


IDG Life Sciences to launch new magazine

03 October, 2003 by Andrew Birmingham

October marks the culmination of our plans to develop a comprehensive suite of life science media products for the Australian market place. Australian Biotechnology News is now well entrenched as the newspaper of choice for local biotechnology leaders. And our acquisition of Today's Life Science has given us great depth across the sector.


Optiscan receives first Pentax order

03 October, 2003 by Tanya Hollis

Optiscan Imaging's (ASX: OIL) partnership with Japan's Pentax Corporation to develop a flexible endomicroscope has taken another step forward with the Melbourne biotech receiving its first major order for the supply of components.


ComBio: Memories are made of this

02 October, 2003 by Graeme O'Neill

It seems that memories are made of... cadherins. While cadherins -- cell adhesion molecules -- do not actually store memories, at the very least they have a major role in organising the basic architecture of the brain, and the dense filigree of fine neural interconnections in which memories are mysteriously stored.


National analytical labs to merge

25 September, 2003 by Susan Williamson

Three major federal analytical labs are to be merged from next July, when a National Measurement Institute will be formed from the amalgamation of the National Measurement Laboratory, the National Standards Commission and the Australian Government Analytical Laboratories.


SA researchers to have better access to equipment, expertise

18 September, 2003 by Tanya Hollis

A new South Australian initiative aims to give scientists in that state easier access to expensive research equipment and expertise.


Brutal honesty marks Iatia's response to a tough 12 months

16 September, 2003 by Melissa Trudinger

Microscopy company Iatia (ASX:IAT) released its annual results last Friday with a brutally honest assessment of their performance over the 2002-2003 year.


Vic govt hands $20m to research institutes

11 September, 2003 by Melissa Trudinger

Medical research institutes in Victoria have received an 11 per cent increase in state government infrastructure funding, with almost AUD$20 million being distributed between 20 institutes.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd